Vasomotor symptoms (VMS), like hot flashes and night sweats, are common menopause symptoms. They’re likely the result of hormonal fluctuations that affect how your body controls its temperature.

Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

Objective: To update and expand The North American Menopause Society’s evidence-based position on nonhormonal management of menopause-associated vasomotor symptoms (VMS), previously a portion of ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

There are estrogen receptors in your breast tissue, which means a drop in estrogen can lead to breast changes, Dr. Streicher ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Those with greater menopausal symptoms had higher scores ... “It is believed that the vasomotor symptoms are correlated with development of white matter hyperintensities in the brain, akin ...

For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive ...

Simon J, Pinkerton J, Maki P, et al. Efficacy of elinzanetant for the treatment of vasomotor symptoms associated with menopause: pooled data from two phase 3 studies. Presented at: AMCP 2025 ...